首页> 外文期刊>Urology >Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer.
【24h】

Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer.

机译:pT3bpN0前列腺癌患者累及精囊的癌症体积的预后意义。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To investigate the prognostic effect of the prostate cancer (PCa) volume involving the seminal vesicles (CVSVs) in the radical prostatectomy specimen from patients with Stage pT3bpN0 PCa. METHODS: We retrospectively reviewed the clinical records of 27 patients with Stage pT3bpN0 PCa who had undergone radical prostatectomy alone. We measured the CVSVs using a grid method on the glass slide under microscopic inspection and investigated the association of the CVSVs with clinicopathologic variables. RESULTS: Prostate-specific antigen (PSA) failure was confirmed in 11 of the 27 patients (41%) during a median follow-up of 34 months. The 3-year PSA failure-free survival rate was 48%. The median CVSVs was 1.14 cm(3). On univariate analysis, a CVSVs of >1.63 cm(3) was associated with positive surgical margins (P = .018), bilateral seminal vesicle involvement (P = .03), a long maximal tumor dimension (P = .031), and a greater preoperative PSA level (P = .0007). The 3-year PSA failure-free survival rate for those with a CVSVs of 1.63 cm(3) was 80% and 0%, respectively (P = .0009). On multivariate analysis, only the PSA level and CVSVs were identified as significant and independent predictors of PSA failure. Stratifying patients into 3 risk groups by these predictors, the PSA failure-free survival rate for patients with a PSA level >or=10 ng/mL and a CVSVs of >1.63 cm(3) was significantly worse than for any other group. CONCLUSIONS: The CVSVs is useful and invaluable as an independent predictor of PSA failure in patients with Stage pT3bpN0 PCa. The measurement of the CVSVs is simple and helped to determine the indication for adjuvant treatment after radical prostatectomy.
机译:目的:研究前列腺癌根治性前列腺切除术标本中pT3bpN0 PCa期患者前列腺精囊(CVSVs)累及精囊(CVSVs)的预后。方法:我们回顾性分析了仅接受前列腺癌根治术的27例pT3bpN0 PCa期患者的临床记录。我们在显微镜检查下使用网格方法在载玻片上测量了CVSV,并研究了CVSV与临床病理变量的关联。结果:在34个月的中位随访期间,在27例患者中有11例(41%)证实了前列腺特异性抗原(PSA)衰竭。 PSA的3年无故障存活率为48%。中位CVSVs为1.14 cm(3)。在单变量分析中,CVSVs> 1.63 cm(3)与手术切缘阳性(P = .018),双侧精囊受累(P = .03),最大肿瘤长(P = .031)相关,并且术前PSA水平更高(P = .0007)。 CVSV小于或等于1.63 cm(3)vs> 1.63 cm(3)的3年PSA无故障生存率分别为80%和0%(P = .0009)。在多变量分析中,只有PSA水平和CVSV被确定为PSA失败的重要且独立的预测因素。根据这些预测因素将患者分为3个风险组,PSA水平>或= 10 ng / mL和CVSV> 1.63 cm(3)的患者的PSA无失败生存率显着低于任何其他组。结论:CVSV作为pT3bpN0 PCa期患者PSA失败的独立预测因子是有用的,并且具有不可估量的价值。 CVSV的测量非常简单,有助于确定前列腺癌根治术后辅助治疗的适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号